Synonyms:
Status: Phase 3
Entry Type: Antibody
Molecule Category: UKNOWN
UNII: 86780VJI1Q

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Receptor tyrosine-protein kinase erbB-3 inhibitor

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Carcinoma, Non-Small-Cell Lung 3 D002289 ClinicalTrials
Head and Neck Neoplasms 2 D006258 ClinicalTrials
Hemangiosarcoma 2 D006394 ClinicalTrials
Breast Neoplasms 2 D001943 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials
Carcinoma, Squamous Cell 1 D002294 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2109406
FDA SRS 86780VJI1Q